These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7471250)

  • 1. [Treatment of vascular retinal lesions with Cavinton (author's transl)].
    Oláh Z; Potocký M
    Cesk Oftalmol; 1981 Jan; 37(1):19-23. PubMed ID: 7471250
    [No Abstract]   [Full Text] [Related]  

  • 2. [The effectiveness of Cavinton in retinal and choroid circulatory disturbances: I. Review of literature and material elaboration (author's transl)].
    Swietliczkowa I; Zeydler-Grzedzielewska L; Baszczyńska-Zielińska B; Braciak W
    Klin Oczna; 1980 Mar; 82(3):147-8. PubMed ID: 7392516
    [No Abstract]   [Full Text] [Related]  

  • 3. [The effectiveness of cavinton in retinal and choroid circulatory disturbances: II. Results of own investigations and discussion (author's transl)].
    Swietliczkowa I; Zeydler-Grzedzielewska L; Baszczyńska-Ziellińska B; Braciak W
    Klin Oczna; 1980 Mar; 82(3):149-52. PubMed ID: 7392517
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of Cavinton drip infusion in ophthalmology. II. Effect of Cavinton drip infusion in eye diseases caused by vascular occlusion or stenosis.
    Imre G
    Ther Hung; 1986; 34(2):84-6. PubMed ID: 3449973
    [No Abstract]   [Full Text] [Related]  

  • 5. Preliminary report on the use of ethyl apovincaminate in affections of the eyeground.
    Brooser G; Anda L; Domán J
    Arzneimittelforschung; 1976; 26(10a):1973-5. PubMed ID: 1037226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of Cavinton on cerebrovascular resistance and its use in ophthalmological patients. A double-blind trial.
    Imre G; Németh B
    Ther Hung; 1981; 29(3):120-3. PubMed ID: 7188137
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of ethyl apovincaminate in ophthalmological therapy.
    Kahán A; Oláh M
    Arzneimittelforschung; 1976; 26(10a):1969-72. PubMed ID: 1037225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Delayed-action pervincamine forte in circulatory disorders of the posterior segment of the eye].
    Bregeat P; Ryzman P
    Rev Otoneuroophtalmol; 1975; 47(5):353-8. PubMed ID: 1215739
    [No Abstract]   [Full Text] [Related]  

  • 9. Therapeutic action of Cavinton in hearing defects of neurological origin.
    Ordögh B; Sárossy D; Klimstein G
    Ther Hung; 1978; 26(1):16-9. PubMed ID: 663871
    [No Abstract]   [Full Text] [Related]  

  • 10. [About cavinton therapy of the patients with brain vascular diseases].
    Nikitina VV; Pravdina AN; Zapatrina OV
    Voen Med Zh; 2007 Feb; 328(2):43-5. PubMed ID: 17508611
    [No Abstract]   [Full Text] [Related]  

  • 11. Observations with cavinton treatment in acute cerebral ischaemic conditions.
    Kovács G
    Ther Hung; 1984; 32(4):155-7. PubMed ID: 6571201
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cavinton treatment of patients with chronic cerebral circulatory insufficiency].
    Ishchenko MM; Shkrobot SI; Ishchenko AM
    Vrach Delo; 1986 Apr; (4):51-4. PubMed ID: 3716339
    [No Abstract]   [Full Text] [Related]  

  • 13. Cavinton in the treatment of acute stroke.
    Kovács L
    Ther Hung; 1985; 33(1):50-7. PubMed ID: 3841999
    [No Abstract]   [Full Text] [Related]  

  • 14. [Role of psychophysiologic characteristics of patients in the efficacy of treatment with cavinton].
    Lil'in ET; Mar'in MI; Trubnikov VI; Vavilova TA
    Sov Med; 1983; (10):111-3. PubMed ID: 6658534
    [No Abstract]   [Full Text] [Related]  

  • 15. Observations with Cavinton (RGH-4405).
    Alberth B; Somogyi E
    Ther Hung; 1979; 27(1):17-27. PubMed ID: 494138
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical and Neuropsychological changes associated with vincamin treatment in cerebrovascular disease (author's transl)].
    Ambrozi L; Bruck J; Tschabitscher H
    Nervenarzt; 1982 Mar; 53(3):141-3. PubMed ID: 7078689
    [No Abstract]   [Full Text] [Related]  

  • 17. Changes in lipoproteins in response to Cavinton administration in aged hyperlipaemic patients.
    Banga I; Gergely I
    Ther Hung; 1982; 30(1):25-9. PubMed ID: 6926906
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of circulatory encephalopathy with Cavinton].
    Lebedeva NV; Chukhrova VA; Solov'ev OU; Nepesov RR
    Klin Med (Mosk); 1997; 75(11):51-3. PubMed ID: 9490359
    [No Abstract]   [Full Text] [Related]  

  • 19. [Cavinton prevention of neurosensory hypoacousis in patients with different forms of tuberculosis].
    Maliavina US; Ovchinnikov IuM; Fasenko VP; Maliev BM; Kalinina MV; Dadasheva BB
    Vestn Otorinolaringol; 2003; (3):35-40. PubMed ID: 12847806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cavinton in the therapy of cerebrovascular disorders].
    Kalvach P; Bauer J; Ságová V
    Cesk Neurol Neurochir; 1982 Nov; 45(6):380-5. PubMed ID: 7151202
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.